Table: Cosmos Pharmaceutical -2019/20 parent results
Jul 10 (Reuters)-
Cosmos Pharmaceutical Corp.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
May 31, 2020 May 31, 2019 May 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 684.40 611.14
(+12.0 pct) (+9.5 pct)
Operating 29.07 24.74
(+17.5 pct) (+8.9 pct)
Recurring 31.54 27.26
(+15.7 pct) (+8.0 pct)
Net 21.42 19.17
(+11.8 pct) (+8.8 pct)
EPS 541.01 yen 484.00 yen
Ann Div 110.00 yen 100.00 yen 55.00 yen
-Q2 Div 50.00 yen 45.00 yen 27.50 yen
-Q4 Div 60.00 yen 55.00 yen 27.50 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T